tradingkey.logo
tradingkey.logo
Search

Journey Medical Corp

DERM
Add to Watchlist
6.590USD
-0.060-0.90%
Market hours ETQuotes delayed by 15 min
178.88MMarket Cap
LossP/E TTM

DERM Cash Flow Statement

You can access the annual and quarterly cash flow statements of Journey Medical Corp to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-84.08%-1.73M
202.72%2.91M
-382.43%-6.28M
-105.96%-2.38M
81.80%-942.00K
43.57%-2.83M
113.47%2.23M
-106.17%-1.16M
-230.41%-5.18M
-425.00%-5.02M
-330.66%-16.52M
357.44%18.75M
220.27%3.97M
-208.14%-956.00K
-19.65%-3.84M
-202.53%-7.28M
---3.30M
--884.00K
---3.21M
--7.10M
Net income from continuing operations
91.78%-312.00K
45.25%-2.23M
-181.99%-1.25M
3.14%-2.31M
-12.94%-3.80M
60.99%-4.07M
170.98%1.52M
-114.24%-2.39M
59.81%-3.36M
-3.02%-10.44M
79.86%-2.14M
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
51.07%-10.64M
5.32%-10.08M
---7.53M
---1.38M
---21.75M
---10.65M
Operating gains losses
-8.93%969.00K
5.73%1.13M
8.56%1.06M
30.71%1.06M
30.55%1.06M
30.84%1.06M
20.37%981.00K
0.00%814.00K
-80.65%815.00K
-23.85%814.00K
-33.58%815.00K
-19.88%814.00K
314.16%4.21M
5.11%1.07M
149.90%1.23M
54.41%1.02M
--1.02M
--1.02M
--491.00K
--658.00K
Deferred tax
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
100.00%0.00
----
----
--8.27M
---3.29M
Other non-cash items
113.90%41.00K
-53.00%149.00K
152.36%100.00K
164.24%221.00K
-226.07%-295.00K
252.22%317.00K
-496.88%-191.00K
-296.57%-344.00K
-71.67%234.00K
-65.78%90.00K
-106.93%-32.00K
-40.88%175.00K
190.85%826.00K
61.35%263.00K
-88.56%462.00K
-97.31%296.00K
--284.00K
--163.00K
--4.04M
--11.02M
Change in working capital
-616.56%-3.87M
296.38%2.88M
-444.88%-7.98M
-265.68%-3.21M
116.51%749.00K
-147.03%-1.46M
90.67%-1.46M
-313.38%-877.00K
-170.67%-4.54M
-56.78%3.11M
-526.68%-15.69M
756.25%411.00K
198.24%6.42M
2230.74%7.20M
20.08%3.68M
-99.49%48.00K
--2.15M
--309.00K
--3.06M
--9.35M
-Change in receivables
-498.41%-11.24M
159.59%4.76M
-1674.16%-11.76M
-175.37%-2.42M
447.54%2.82M
-247.48%-7.99M
110.41%747.00K
-109.93%-877.00K
-107.78%-812.00K
1062.45%5.42M
-14170.59%-7.18M
10538.55%8.83M
320.44%10.43M
105.83%466.00K
-99.40%51.00K
101.50%83.00K
--2.48M
---8.00M
--8.51M
---5.54M
-Change in inventory
419.10%1.14M
-82.84%332.00K
183.01%2.19M
149.21%1.03M
-139.87%-356.00K
617.38%1.94M
-423.11%-2.64M
-283.98%-2.10M
-19.69%893.00K
-142.45%-374.00K
-23.62%818.00K
38.76%1.14M
1223.81%1.11M
476.50%881.00K
-38.87%1.07M
-69.53%823.00K
--84.00K
---234.00K
--1.75M
--2.70M
-Change in prepaid expenses
966.67%728.00K
-110.77%-88.00K
11.78%-1.74M
-27.75%841.00K
-149.12%-84.00K
-19.19%817.00K
26.05%-1.97M
33.49%1.16M
-74.89%171.00K
21.51%1.01M
-12.55%-2.66M
837.63%872.00K
18.85%681.00K
0.24%832.00K
-149.68%-2.37M
111.98%93.00K
--573.00K
--830.00K
---948.00K
---776.00K
-Change in other current assets
----
----
----
----
----
----
--6.00K
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-98.66%8.00K
101.17%7.00K
--8.00K
--32.00K
--599.00K
---600.00K
Cash from non-recurring investing activities
Cash from operating activities
-84.08%-1.73M
202.72%2.91M
-382.43%-6.28M
-105.96%-2.38M
81.80%-942.00K
43.57%-2.83M
113.47%2.23M
-106.17%-1.16M
-230.41%-5.18M
-425.00%-5.02M
-330.66%-16.52M
357.44%18.75M
220.27%3.97M
-208.14%-956.00K
-19.65%-3.84M
-202.53%-7.28M
---3.30M
--884.00K
---3.21M
--7.10M
Investing cash flow
Net cash from continuing investing activities
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
-75.00%5.00M
-100.00%0.00
-100.00%0.00
--0.00
--20.00M
--1.20M
--8.80M
Capital expenditures
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
-75.00%5.00M
-100.00%0.00
127.27%20.00M
--0.00
--20.00M
--1.20M
--8.80M
Net cash flow from intangible asset transactions
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
-75.00%5.00M
-100.00%0.00
-100.00%0.00
--0.00
--20.00M
--1.20M
--8.80M
Cash from non-current investing activities
Net cash flow from investing activities
----
----
----
----
----
----
---15.00M
--0.00
--0.00
100.00%0.00
--0.00
--0.00
--0.00
75.00%-5.00M
100.00%0.00
100.00%0.00
--0.00
---20.00M
---1.20M
---8.80M
Financing cash flow
Cash flow from continuous financing activities
-4.24%158.00K
-93.88%220.00K
-48.90%5.43M
2493.88%7.04M
-96.72%165.00K
119.73%3.60M
-44.72%10.62M
97.32%-294.00K
138.44%5.03M
3048.08%1.64M
1926.37%19.21M
-372.34%-10.98M
-11890.99%-13.09M
-99.54%52.00K
-97.02%948.00K
-64.04%4.03M
--111.00K
--11.37M
--31.80M
--11.21M
Net cash flow from debt Issuance/repayment
----
100.00%0.00
-100.00%0.00
100.00%0.00
-100.00%0.00
---625.00K
-70.50%4.42M
93.86%-675.00K
138.46%5.00M
-100.00%0.00
1482.28%15.00M
-375.00%-11.00M
---13.00M
-99.56%52.00K
16.75%948.00K
-43.18%4.00M
--0.00
--11.95M
--812.00K
--7.04M
Net cash flow from common stock issuance/repurchase
--0.00
49.49%148.00K
---1.00K
-4.03%119.00K
--0.00
16.47%99.00K
--0.00
--124.00K
--0.00
--85.00K
----
----
----
----
----
----
----
----
--32.54M
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--4.63M
Proceeds from stock option exercised by employees
-4.24%158.00K
-4.00%72.00K
-84.44%7.00K
63.49%103.00K
432.26%165.00K
10.29%75.00K
-53.13%45.00K
186.36%63.00K
933.33%31.00K
--68.00K
--96.00K
-29.03%22.00K
-97.30%3.00K
----
--0.00
--31.00K
--111.00K
--0.00
--0.00
----
Net cash flow from other financing activities
--0.00
-100.00%0.00
-11.86%5.42M
3413.40%6.82M
--0.00
172.78%4.05M
49.47%6.15M
--194.00K
100.00%0.00
--1.48M
--4.11M
--0.00
---91.00K
100.00%0.00
100.00%0.00
100.00%0.00
--0.00
---585.00K
---1.55M
---464.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
-4.24%158.00K
-93.88%220.00K
-48.90%5.43M
2493.88%7.04M
-96.72%165.00K
119.73%3.60M
-44.72%10.62M
97.32%-294.00K
138.44%5.03M
3048.08%1.64M
1926.37%19.21M
-372.34%-10.98M
-11890.99%-13.09M
-99.54%52.00K
-97.02%948.00K
-64.04%4.03M
--111.00K
--11.37M
--31.80M
--11.21M
Net cash flow
Beginning cash balance
----
18.64%24.09M
11.07%24.95M
-15.13%20.29M
-12.42%21.07M
-26.00%20.30M
-9.24%22.46M
40.82%23.91M
-7.82%24.06M
-14.26%27.44M
-29.07%24.75M
-55.48%16.98M
-36.85%26.10M
-34.80%32.00M
60.87%34.89M
213.26%38.14M
--41.33M
--49.08M
--21.69M
--12.18M
Current period cash flow changes
-102.83%-1.58M
309.02%3.13M
60.20%-858.00K
420.81%4.66M
-435.86%-777.00K
122.62%765.00K
-180.15%-2.16M
-118.68%-1.45M
98.41%-145.00K
42.72%-3.38M
193.14%2.69M
338.97%7.77M
-185.95%-9.12M
23.82%-5.90M
-110.54%-2.89M
-134.17%-3.25M
---3.19M
---7.75M
--27.39M
--9.51M
Ending cash balance
26.36%25.64M
29.18%27.22M
18.64%24.09M
11.07%24.95M
-15.13%20.29M
-12.42%21.07M
-26.00%20.30M
-9.24%22.46M
40.82%23.91M
-7.82%24.06M
-14.26%27.44M
-29.07%24.75M
-55.48%16.98M
-36.85%26.10M
-34.80%32.00M
60.87%34.89M
--38.14M
--41.33M
--49.08M
--21.69M
Free cash flow
----
----
----
----
----
----
----
----
-230.41%-5.18M
15.73%-5.02M
-330.66%-16.52M
168.72%18.75M
220.27%3.97M
68.84%-5.96M
12.94%-3.84M
-1506.71%-27.28M
---3.30M
---19.12M
---4.41M
---1.70M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Journey Medical Corp Generate?

Journey Medical Corp generated -12.44M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Journey Medical Corp's Operating Cash Flow Change Year Over Year?

Journey Medical Corp's operating cash flow increased by -36.31% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Journey Medical Corp's Financing Cash Flow Changed?

Journey Medical Corp used 16.23M in financing activities in the latest quarter.

What is free cash flow and why does it matter for DERM?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.